What CrisprBits does
Founded in 2020, CrisprBits operates in Health Tech industry. Initially focusing on developing precise gene-editing technologies, the company has evolved to offer a wider array of applications in diagnostics and therapeutics. CrisprBits made strides by enhancing its CRISPR-based diagnostic platform to improve disease detection capabilities. The company has expanded its offerings to include services tailored for personalized medicine and agricultural biotech solutions. Competing with companies such as Eyestem and 4baseCare.
Who runs it
Funding and finances
Why this matters to you: funding stage is a rough proxy for how long the runway is and how much structure to expect. It is not a promise, and a profitable bootstrapped company can be the safer bet.
Check the company’s own careers page — linked at the top — before a job board. A role appears there first, sometimes weeks before it is syndicated anywhere else.
Questions and experiences
Nobody has asked anything about CrisprBits yet. If you have interviewed here, what you know is worth more to the next person than anything on the rest of this page.
Company facts compiled from public sources and last refreshed 9 September 2026. Details change; treat the company’s own site as the authority.